“…The C-ERMAD also harbors a conserved regulatory threonine residue (T567, T564, and T558 in ezrin, radixin, and moesin, respectively) that is phosphorylated upon stimulation to maintain the active open conformation (Simons et al, 1998). ERMs were shown to control cell morphogenesis during mitosis (Carreno et al, 2008; De Jamblinne et al, 2020; Kunda et al, 2008; Leguay et al, 2022; Roubinet et al, 2011), cell migration (Arpin et al, 2011; Barik et al, 2022; Hoskin et al, 2015) and cell invasion (Estecha et al, 2009; Song et al, 2020). In a pathological context, high levels of ezrin, radixin, or moesin expression correlate with a high rate of metastasis and poor prognosis in several cancers (Clucas and Valderrama, 2014).…”